Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

著者: Elisa Pose, Laura Napoleone, Ahmed Adel Amin, Daniela Campion, César Jiménez, Salvatore Piano, Olivier Roux, Frank Erhard Uschner, Koos de Wit, Giacomo Zaccherini, Carlo Alessandria, Paolo Angeli, Mauro Bernardi, Ulrich Beuers, Paolo Caraceni, François Durand, Rajeshwar P. Mookerjee, Jonel Trebicka, Vı́ctor Vargas, Raúl J. Andrade, Marta Carol, Judit Pich, Juan Pablo Ferrero, Gema Doménech, Marta Llopis, Ferràn Torres, Patrick S. Kamath, Juan G. Abraldeṣ, Elsa Solà, Pere Ginès - The Lancet 2019 被引用: 145